Artificial
Artificial is a Palo Alto-based enterprise software company, founded in 2018, that builds an AI-integrated lab automation platform for pharmaceutical R&D, diagnostic, and research laboratories. It sells via enterprise subscriptions targeting imaging, automation, and informatics workflows.
- Company typePrivate
- Founded2018
- HeadquartersPalo Alto, United States
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What Artificial does
Artificial is a Palo Alto-based private software company founded in 2018 that builds an AI-integrated lab automation platform for enterprise customers in life sciences and diagnostics. The platform is positioned as an embedded operating layer across three lab workflow domains: imaging systems, automation platforms, and informatics — intended to enable high-throughput testing, automate repetitive laboratory tasks, and improve diagnostic accuracy. The company targets three primary customer segments: pharmaceutical R&D laboratories (primary), diagnostic laboratories, and academic/private research institutions, addressing pain points such as pharmaceutical R&D pressure, diagnostic workforce shortages, and laboratory modernization initiatives.
The core technology is described as an AI-integrated lab automation platform whose differentiator is integration and interoperability across existing lab infrastructure, with AI embedded into imaging, automation, and informatics rather than offered as a standalone analytics product. Specific underlying models, data assets, patents, and technical architecture details are not disclosed in the available sources, limiting technical due diligence. The company sells through an enterprise B2B field sales motion, with revenue generated via enterprise software licensing and subscription. Pricing is not publicly disclosed and is presumed to be quote-based, consistent with enterprise SaaS norms.
The company is venture-backed, having closed a $21.5 million Series A in May 2021 led by M12 (Microsoft's venture fund) with participation from Playground Global and AME Cloud Ventures. Leadership includes CEO and co-founder David Fuller, co-founder and Chief Product Officer Nikhita Singh, and VP of Engineering James Branigan. Headcount sits in the 11-50 range. The company currently serves North America (USA), with stated intent to grow global operations. A notable data point: the artificial.com domain is currently listed for sale by a third-party domain marketplace (Snagged) at a $250,000 minimum offer, which is ambiguous — it may reflect lapsed domain ownership, a separate brand domain, or unrelated third-party listing — and warrants verification before any investment decision.
Artificial firmographics
Firmographics- Name
- Artificial
- Website
- https://artificial.com
- Company type
- Private
- Founded year
- 2018
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Artificial is a Palo Alto-based enterprise software company, founded in 2018, that builds an AI-integrated lab automation platform for pharmaceutical R&D, diagnostic, and research laboratories. It sells via enterprise subscriptions targeting imaging, automation, and informatics workflows.
- Ownership category
- akta.pro rank
Artificial industry classification
Industry- Product category
- Laboratory Automation Software
- NAICS
- Computer Systems Design and Related Services (54151)
- SIC
- Services-Computer Integrated Systems Design (7373)
- akta.pro primary industry
- Lab Automation, Instrument Control & Workflow Orchestration Software (HLAGAJAG)
- akta.pro secondary industry
- AI Application Enablement Platforms (Copilot/Agent Frameworks, SDKs) (HDAEANAJ)
Keywords
Where Artificial is headquartered
LocationHeadquarters
- HQ city
- Palo Alto
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Artificial business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations
Revenue model
- Enterprise Software Licenses/Subscriptions: Artificial generates revenue through enterprise software licensing and subscriptions for its lab automation platform, as evidenced by its venture funding and focus on product development acceleration and global operations expansion.
Go-to-market motion1 record
Artificial product offering
Product offeringCore offering
Artificial develops an AI-integrated lab automation platform that delivers intelligent imaging, automation, and informatics capabilities for modern research and diagnostics laboratories. The platform enables high-throughput testing, automates repetitive laboratory tasks, and improves diagnostics accuracy for pharmaceutical R&D, clinical diagnostic, and research institution customers. It functions as an embedded operating layer within laboratory infrastructure rather than a standalone analytics tool.
Product overview
No product information available in the provided sources. The sources do not contain details from the actual company website or product pages of Artificial (the Palo Alto-based lab automation software company). One source references artificial.com as a domain name being offered for sale, which is unrelated to the company's actual web presence.
Differentiator
Problem solved
Functional benefit
Products and services
- Lab Automation Platform
Quantifiable outcome
- AI in Lab Automation market projected to grow from USD 456.5 million (2026) to USD 1.39 billion by 2036 at 11.8% CAGR
Companies that use Artificial
Customer profileSegments3 records
Ideal customer profiles3 records
Artificial technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
Artificial partnerships and signals
Strategic signalScale indicators2 records
Recent moves3 records
Expansion highlights4 records
Artificial competitors and assessment
Company assessmentBroad incumbents
- Sartorius: Sartorius provides bioprocess and lab analytics software alongside its instruments, serving similar biopharma customers with embedded data and automation capabilities — a broad incumbent adjacent to Artificial's lab automation thesis.
- Thermo Fisher Scientific (SampleManager LIMS): Thermo Fisher's SampleManager LIMS and broader digital lab offerings target the same pharma and diagnostic lab buyers, but as part of a much larger life sciences tools portfolio — a broad incumbent rather than a focused automation platform.
- Agilent Technologies (CrossLab / lab software): Agilent's CrossLab and OpenLab lab informatics and automation software serve pharmaceutical and diagnostic labs, overlapping with Artificial's offering as part of a broad analytical instruments and software portfolio.
Emerging players
- Scitara: Scitara provides a lab integration platform (Scientific Integration Platform) connecting instruments, LIMS, and informatics — an emerging competitor specifically focused on the lab interoperability wedge Artificial claims.
- TetraScience: TetraScience is a life sciences R&D data cloud that integrates lab instrument data into analytics-ready pipelines — a narrower but overlapping play on the lab data interoperability layer Artificial emphasizes.
Direct peers
- Benchling: Benchling is a cloud-based life sciences R&D platform covering lab notebooks, inventory, and workflow automation for pharma and biotech — directly comparable to Artificial's lab automation platform targeting the same buyer profile.
- LabVantage Solutions: LabVantage provides an enterprise LIMS and lab informatics platform used by pharmaceutical, diagnostic, and research laboratories, competing for the same lab modernization budgets Artificial targets.
- LabWare: LabWare is an established LIMS and laboratory automation software vendor serving regulated labs in pharma, diagnostics, and research — a like-for-like competitor for the lab automation platform category.
- Dotmatics: Dotmatics offers a scientific R&D informatics platform spanning ELN, data management, and lab workflow automation for life sciences — overlapping Artificial's pharma R&D and research institution use cases.
- Genedata: Genedata delivers enterprise scientific informatics and workflow automation for biopharma R&D, including experiment automation and data integration — directly comparable to Artificial's embedded automation thesis.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat3 records
Key risks6 records
Key highlights6 records
Customer concentration
Artificial social profiles
Digital presenceArtificial financial estimates
Financial estimateRevenue estimate
Valuation estimate
Artificial leadership team
Management profileNumber of profiles
Profiles3 records
Artificial funding detail
Funding detailFunding overview
Funding rounds1 record
Investors3 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Artificial M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Artificial
What does Artificial do?
Artificial develops an AI-integrated lab automation platform that delivers intelligent imaging, automation, and informatics capabilities for modern research and diagnostics laboratories. The platform enables high-throughput testing, automates repetitive laboratory tasks, and improves diagnostics accuracy for pharmaceutical R&D, clinical diagnostic, and research institution customers. It functions as an embedded operating layer within laboratory infrastructure rather than a standalone analytics tool.
Is Artificial a public or private company?
Artificial is a private company. It is classified as venture growth investor backed and is currently operating.
When was Artificial founded?
Artificial was founded in 2018. It employs 11 to 50 people.
Where is Artificial based?
Artificial is headquartered in Palo Alto, United States, in the North America region.
How does Artificial make money?
One revenue line is on record: enterprise Software Licenses/Subscriptions.
Who are Artificial's main competitors?
Broad incumbents on record are Sartorius, Thermo Fisher Scientific (SampleManager LIMS) and Agilent Technologies (CrossLab / lab software). Emerging players are Scitara and TetraScience. Direct peers are Benchling, LabVantage Solutions, LabWare, Dotmatics and Genedata.
Does Artificial have an API?
No public API is recorded for Artificial.
What industry is Artificial in?
Artificial's product category is Laboratory Automation Software. Its primary akta.pro industry code is HLAGAJAG, Lab Automation, Instrument Control & Workflow Orchestration Software, with a secondary code of HDAEANAJ, AI Application Enablement Platforms (Copilot/Agent Frameworks, SDKs). Its NAICS code is 54151 and its SIC code is 7373.